In a technology review meeting, once the demonstration runs cleanly, the sequence of questions in the room is remarkably stable: scalability first, then certification, then the cost of integrating with existing systems, and last — frequently outside the formal agenda, compressed into the final minutes of the session — the question of whose budget this capability would sit in and which line item it would displace. The ordering is not accidental. The technical questions are the ones everyone present can answer with data they control, whereas the final question depends entirely on the behaviour of a party who is not in the room and whose answer nobody holds. Energy in the meeting therefore concentrates around answerable questions, while the unanswerable one is deferred to the next session as a matter of course, and after several quarters of deferral it stops being asked at all.
The same pattern shows a second face in portfolio reporting. Where pilot counts rise quarter over quarter while conversion into paid contracts stays flat, the issue is not sales execution but a definitional problem concerning what a pilot actually measures; renewal alone carries no demand signal, whereas renewal at unchanged price, funded from an existing operating line on the counterparty's side, does. In a parallel way, the interest expressed by the sponsor on the customer side is usually genuine, yet whether that interest coincides with budget authority is a separate question entirely — the enthusiasm of a manager whose mandate is to scout emerging technology reflects that mandate rather than the institution's purchasing behaviour. Failing to separate these two signals produces the familiar condition in which the commercialization timeline slides forward by six months, repeatedly, without anyone being able to name the cause precisely.
The name of this pattern is solution in search of a problem — a solution working backwards to locate the problem that would justify it. The mechanism operates not through carelessness or bad faith but through an asymmetry between two classes of information: capability is internal, observable, measurable, and improvable by an internal development decision, while need is external, visible only through indirect signals, and improvable by no internal decision whatsoever. A team gravitates toward optimizing the variable it can both measure and influence, which is entirely reasonable on its own terms; the difficulty is not that optimization continues but that progress in optimization begins to substitute for validation. As the capability matures, the definition of the problem narrows quietly toward the shape the capability can serve, until the question the product answers becomes identical to the question the product is able to answer.
A diagnosis that misses the conditions under which this tendency is functional is an incomplete diagnosis. Where a genuinely new category is at stake, demand does not pre-exist; a counterparty cannot have opened a budget line for a capability it has never experienced, so validation only becomes possible after construction. As long as build cost stays low, commitment remains reversible, and the learning loop is short, building first and asking afterward is a rational shortcut, and weighting the exploration side of the exploration-exploitation tension is very probably the correct early-stage choice. The fracture begins when the condition changes and the shortcut does not: once capital commitment crosses a threshold, once procurement orders are placed, once a production line is configured, or once a facility decision is fixed at FID, the same behaviour ceases to be exploration and becomes an irreversible wager.
The organizational layer renders this transition invisible. When a team is assembled around a capability, the justification for that team's existence becomes tied to the capability's continuation, and the cost of a negative answer to the need question turns personal; from that point onward the internal validation loop starts operating at higher resolution than the external signal. The first customer, occupying the position of a travelling companion rather than a buyer, may be purchasing because the relationship warrants it rather than because the need warrants it — yet in the income statement the two purchases are indistinguishable. The distinction between formal authority and purchasing authority is decisive precisely here: where the unit conducting technical evaluation is not the unit carrying the budget, a favourable technical opinion converts into a further round of evaluation rather than into a contract.
The institutional cost surfaces first in the cash cycle. Capitalized development expenditure sits on the balance sheet as an intangible asset whose recoverability rests on a revenue line that does not yet exist, and the finished-goods inventory accompanying it is a position whose turnover cannot be calculated because counterparty behaviour remains unverified. As the sales cycle lengthens, working capital requirement grows in proportion not to revenue but to the fixed cost base waiting on revenue, and the company finds itself inside a funding gap it never loses in any single quarter and never closes in any single quarter either. The most misleading feature of this structure is that no individual line appears abnormal in isolation; the anomaly resides not in the items themselves but in how the ratios among them move over time.
At the diligence table, by contrast, the cost registers directly in price. The first move of an acquirer or an investment committee is to segment revenue not by product line but by the source of payment: revenue drawn from the counterparty's operating budget and revenue drawn from an innovation, R&D, or exploration budget are valued at different multiples, because the latter carries not contract renewal risk but the counterparty's budget priority risk. Where that distinction remains unresolved, the typical outcome is that headline valuation is preserved while risk migrates into structure — an earn-out trigger conditioned on demonstrated revenue recurrence, renewal commitments imposed as conditions precedent to closing, an expanded representations and warranties package tied to customer concentration, and an escrow ratio above the customary band. On the sell side this is experienced less as a price negotiation than as an extended closing timetable.
In capital-intensive projects the same mechanism appears one layer up, at technology selection. Where a facility, a storage configuration, or a process line is chosen because it deploys a capability already held or accessible through a supplier relationship, rather than because it solves a problem a counterparty is prepared to pay for, the cost of that selection becomes visible not in engineering but in financing. The lender's independent technical adviser looks, before asking whether the technology works, at whether the output has a contracted off-taker; a configuration with a weak off-take side, however faultless technically, produces a margin that compresses rapidly under DSCR sensitivity and tightens the covenant package accordingly. Unvalidated need thus begins as an engineering matter, continues as a contracting matter, and is ultimately priced as a difference in cost of capital.
What neutralizes this tendency is institutional architecture rather than individual awareness, and that architecture has four separable components. The first is that the need record precedes the solution record and is created at the moment of proposal: which party, in which budget line, spends what today, and what breaks if this solution disappears, must be written down before any development gate opens, since recording at proposal rather than at approval structurally forecloses retroactive justification. The second is a hierarchy of demand evidence — expressed interest, interest voiced by a person holding signature authority, interest validated by payment, and interest renewed at unchanged price do not carry equal weight. The third is that stage gates are tied to external behaviour rather than internal progress, the criterion being an observed commitment movement on the counterparty's side rather than a delivered module. The fourth is institutionalizing the counter-argument role: ahead of any material commitment, someone must be tasked with recording the thesis that the need does not exist, and that person's career outcome must not depend on the thesis being rejected.
BEIREK's intervention in this problem begins by separating the project's technical file from its demand file. In development-stage engagements we maintain a demand evidence chain independent of the record tracking engineering progress; within that chain each signal is tagged according to the budget authority of its source and the line from which payment originates, and the only route to upgrading a tag is an observed behaviour on the counterparty's side, never an internal assessment. Stage gates are anchored to threshold crossings in that chain rather than to calendar dates, so that the question debated at the final gate before FID concerns the contracting capacity of the output's buyer rather than the maturity of the technology. The stakeholder pre-mortem is run with the same discipline: positioned eighteen months past the commitment date, it records which signals, observable today, would indicate the scenario in which need was never validated, and those signals are carried into the subsequent review rhythm as standing agenda items.
The institutional meaning of this mechanism is not getting a single decision right but deliberately purchasing the cost of keeping the decision reversible; the premium paid for flexibility during exploration is typically an order of magnitude below the correction cost payable once commitment has hardened. The operative question is therefore neither whether a technology works nor whether the team believes in it, but rather which party would face a concrete gap, in which budget line, if this capability vanished today, and who has been filling that gap until now, at what price. Absent a written answer to that question, what is held is not a product but a capability that has yet to locate its problem — and from the moment a capability is carried on the balance sheet as though it were a product, the valuation gap has already formed.